Anavex Life Sciences Corp (AVXL)

[gbrown6332]

"ANAVEX will host a R&D Day for investors and analysts on Tuesday, June 21, 2022. Anavex’s R&D Day will include presentations from the Company’s leadership team with a focus on the Company’s clinical development pipeline. Additional details will follow closer to the event."

Bourbon referenced his historical interests in a small biotech, Advaxis which has experienced a dramatic rise and fall. I was also a true believer. When they were still a going concern, Advaxis hosted an annual investor day which were destination events. I traveled to a meeting in Philadelphia and a second in NYC. The company leaders and researchers presented updates on trials, regulatory efforts and clinical development. More importantly, time was provided after the formal program to engage with the company leaders up close and personal during an informal reception. They were guarded, but would share as much as they felt comfortable doing. There were a number of analyst present who followed the company and it was very interesting to get their insights. A few of the larger institutional investors sent representatives as well.

The format of the announced Anavex R&D meeting isn't yet clear. It will offer a lot more value if it's "in person" participation rather than a virtual event and hopefully some members of this board can attend.

G.B.